Trial intelligence / Profile preview

Licaminlimab in Acute Anterior Uveitis

NCT02482129Phase 2Completed

Sponsor
Alcon Inc.
Start
Jul 2015
Primary completion
Mar 2016
Modality
scFv Fragments
01

Overview

A Phase 2 trial of licaminlimab in acute anterior uveitis (AAU), sponsored by Alcon Inc.. Started Jul 2015; status: completed.

02

Drugs

licaminlimab
03

Conditions

acute anterior uveitis (AAU)

Beyond the preview

Go deeper on NCT02482129.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02482129.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call